Search research articles
Contact Us
Filters
Showing results (11-20 of 181) with videos related to
Page
of 19
Sort By:
Schmerz (Berlin, Germany)
|
June 12, 2003
[Therapy with opioids in liver or renal failure]
I Tegeder, G Geisslinger, J Lötsch
International Journal of Clinical Pharmacology and Therapeutics
|
February 6, 2004
Programming of a flexible computer simulation to visualize pharmacokinetic-pharmacodynamic models
J Lötsch, G Kobal, G Geisslinger
Schmerz (Berlin, Germany)
|
September 1, 2005
[Are polymorphisms in the mu-opioid receptor important for opioid therapy?]
J Lötsch, R Freynhagen, G Geisslinger
Journal of Chromatography
|
December 2, 1992
Stereoselective determination of the enantiomers of methadone in plasma using high-performance liquid chromatography
N Schmidt, K Brune, G Geisslinger
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 20, 2001
Cyclooxygenase-independent actions of cyclooxygenase inhibitors
I Tegeder, J Pfeilschifter, G Geisslinger
European Journal of Pharmacology
|
April 1, 1994
Opioid receptor agonist potencies of morphine and morphine-6-glucuronide in the guinea-pig ileum
N Schmidt, K Brune, G Geisslinger
Clinical Pharmacology and Therapeutics
|
November 24, 2001
Stereoselective pharmacokinetics of ketamine: R(-)-ketamine inhibits the elimination of S(+)-ketamine
H Ihmsen, G Geisslinger, J Schüttler
Clinical Pharmacokinetics
|
August 19, 1999
Pharmacokinetics of opioids in liver disease
I Tegeder, J Lötsch, G Geisslinger
Clinical Pharmacokinetics
|
April 16, 1998
Drug acetylation in liver disease
M Levy, Y Caraco, G Geisslinger
Pain
|
April 27, 2001
Release of glutamate, nitric oxide and prostaglandin E2 and metabolic activity in the spinal cord of rats following peripheral nociceptive stimulation
G Vetter, G Geisslinger, I Tegeder
Page
of 19
Search research articles
Search
Showing results (11-20 of 181) with videos related to
Sort By:
Page
of 19
Schmerz (Berlin, Germany)
|
June 12, 2003
[Therapy with opioids in liver or renal failure]
I Tegeder, G Geisslinger, J Lötsch
International Journal of Clinical Pharmacology and Therapeutics
|
February 6, 2004
Programming of a flexible computer simulation to visualize pharmacokinetic-pharmacodynamic models
J Lötsch, G Kobal, G Geisslinger
Schmerz (Berlin, Germany)
|
September 1, 2005
[Are polymorphisms in the mu-opioid receptor important for opioid therapy?]
J Lötsch, R Freynhagen, G Geisslinger
Journal of Chromatography
|
December 2, 1992
Stereoselective determination of the enantiomers of methadone in plasma using high-performance liquid chromatography
N Schmidt, K Brune, G Geisslinger
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 20, 2001
Cyclooxygenase-independent actions of cyclooxygenase inhibitors
I Tegeder, J Pfeilschifter, G Geisslinger
European Journal of Pharmacology
|
April 1, 1994
Opioid receptor agonist potencies of morphine and morphine-6-glucuronide in the guinea-pig ileum
N Schmidt, K Brune, G Geisslinger
Clinical Pharmacology and Therapeutics
|
November 24, 2001
Stereoselective pharmacokinetics of ketamine: R(-)-ketamine inhibits the elimination of S(+)-ketamine
H Ihmsen, G Geisslinger, J Schüttler
Clinical Pharmacokinetics
|
August 19, 1999
Pharmacokinetics of opioids in liver disease
I Tegeder, J Lötsch, G Geisslinger
Clinical Pharmacokinetics
|
April 16, 1998
Drug acetylation in liver disease
M Levy, Y Caraco, G Geisslinger
Pain
|
April 27, 2001
Release of glutamate, nitric oxide and prostaglandin E2 and metabolic activity in the spinal cord of rats following peripheral nociceptive stimulation
G Vetter, G Geisslinger, I Tegeder
Page
of 19